ENTITY
Celltrion Pharm

Celltrion Pharm (068760 KS)

116
Analysis
Health CareSouth Korea
Celltrion Pharm Inc. manufactures and sells pharmaceutical products. The Company products inclue drugs for for hepatic diseases, digestion, diabetes, cold and fever, anti-inflammatory, and veterinary medical products. Celltrion also provides pharmaceutical raw materials.
more
bullishCelltrion Inc
24 Oct 2023 10:13

Celltrion Merger: Index Implications

Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS) shareholders have approved the merger. The last trading day is expected to be 28...

Logo
1.1k Views
Share
bullishJMDC
01 Oct 2023 07:10

(Mostly) Asia M&A, Sept 2023: JMDC, Pact, Takisawa, Golden Eagle Energy, Dic Corp

For the month of September, 8 new deals were discussed on Smartkarma with an overall deal size of ~US$2bn. The average premium for the new deals...

Logo
857 Views
Share
bullishFadu
25 Sep 2023 17:33

KOSDAQ 150 Rebalance Candidates in December 2023

In this insight, we discuss the potential inclusion and exclusion candidates for the KOSDAQ 150 rebalance in December 2023.

Logo
523 Views
Share
bullishHLB Inc
28 Aug 2023 14:00

Positioning for the Timing of HLB, the Latest Target in the KOSDAQ Exodus

This post explores why top KOSDAQ companies are hurrying to shift to KOSPI in the second half of this year and discusses the best timing for...

Logo
507 Views
Share
20 Aug 2023 07:19

Index Rebalance & ETF Flow Recap: ASX, NEXT50, MVMVA, MVMVW, Celltrion, Brilliance, KQ150, HSCI

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
486 Views
Share
x